Simple Summary Hepatocellular carcinoma (HCC) is the most common type of primary liver
cancer and its incidence is steadily increasing. The development of HCC is a complex, multi …

Background Patients with advanced cirrhosis are at high risk of developing clinically
significant portal hypertension (CSPH). We analyzed the gene expression profile of …

Salvia triloba (S. triloba) is an herb inherently linked to traditional medicine systems in the
Eastern Mediterranean region. There is minimal experimental evidence however, regarding …

Hepatocellular carcinoma (HCC) is the main tumor of the liver and is the sixth most
frequently diagnosed tumor in the world. It is the evolution of chronic hepatic injury …

Background Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related
mortality worldwide. It is a highly heterogeneous disease with poor prognosis and limited …

Globally, hepatocellular carcinoma (HCC) is a significant cause of mortality and morbidity
among chronically infected HCV patients. It is established that HCV is a primary risk factor …

The incidence of hepatocellular carcinoma (HCC) ranks first among primary liver cancers,
and its mortality rate exhibits a consistent annual increase. The treatment of HCC has …

Abstract Background Methylated septin 9 (mSEPT9) has a role in hepatocarcinogenesis. We
evaluated mSEPT9 performance in patients with hepatocellular carcinoma (HCC) and those …

Salinomycin (SAL) is a monocarboxylic polyether ionophore antibiotic isolated from
Streptomyces albus. It exhibits an effective antitumor potential against numerous human …

The pathogenicity of HCC could be enhanced by TNF-α and NFκB, which are crucial parts of
the inflammatory pathway inside the HCC microenvironment. Therefore, we aimed to …